ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
Wilba32
|
542 |
212K |
13 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
542
|
212K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
ASX Hot too!
|
|
Wilba32
|
104 |
37K |
3 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
104
|
37K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
ASX Hot too!
|
|
Wilba32
|
104 |
37K |
9 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
104
|
37K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.6M |
21 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
17K
|
6.6M
|
21
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.6M |
7 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
17K
|
6.6M
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Wilba32
|
221 |
46K |
23 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
221
|
46K
|
23
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast stock(rock)-take March 2024
|
|
Wilba32
|
272 |
111K |
12 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
272
|
111K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast stock(rock)-take March 2024
|
|
Wilba32
|
272 |
111K |
11 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
272
|
111K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
Wilba32
|
567 |
211K |
2 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
567
|
211K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
ASX Hot too!
|
|
Wilba32
|
104 |
37K |
8 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
104
|
37K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Wilba32
|
5.0K |
2.4M |
18 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
5.0K
|
2.4M
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast stock(rock)-take March 2024
|
|
Wilba32
|
272 |
111K |
7 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
272
|
111K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.6M |
18 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
17K
|
6.6M
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
Wilba32
|
549 |
170K |
4 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
549
|
170K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
Wilba32
|
549 |
170K |
5 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
549
|
170K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.6M |
20 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
17K
|
6.6M
|
20
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
Wilba32
|
549 |
170K |
27 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
549
|
170K
|
27
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Wilba32
|
133 |
44K |
5 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
133
|
44K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Wilba32
|
133 |
44K |
9 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
133
|
44K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast stock(rock)-take March 2024
|
|
Wilba32
|
272 |
111K |
9 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
272
|
111K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Wilba32
|
551 |
196K |
2 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
551
|
196K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
9.4K |
2.7M |
3 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
9.4K
|
2.7M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Wilba32
|
133 |
44K |
2 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
133
|
44K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
9.4K |
2.7M |
10 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
9.4K
|
2.7M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
9.4K |
2.7M |
9 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
9.4K
|
2.7M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Wilba32
|
133 |
44K |
1 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
133
|
44K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Wilba32
|
133 |
44K |
8 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
133
|
44K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Wilba32
|
133 |
44K |
12 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
133
|
44K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
9.4K |
2.7M |
3 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
9.4K
|
2.7M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
Wilba32
|
542 |
212K |
5 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
542
|
212K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
9.4K |
2.7M |
8 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
9.4K
|
2.7M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Wilba32
|
5.0K |
2.4M |
9 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
5.0K
|
2.4M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
9.4K |
2.7M |
8 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
9.4K
|
2.7M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.6M |
4 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
17K
|
6.6M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.6M |
7 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
17K
|
6.6M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.6M |
15 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
17K
|
6.6M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Next price sensitive announcement MSB
|
|
Wilba32
|
41 |
17K |
1 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
41
|
17K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Next price sensitive announcement MSB
|
|
Wilba32
|
41 |
17K |
5 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
41
|
17K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Next price sensitive announcement MSB
|
|
Wilba32
|
41 |
17K |
9 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
41
|
17K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
9.4K |
2.7M |
10 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
9.4K
|
2.7M
|
10
|
|
General
|
|
Re:
Ads that cover whole screen and don’t go away
|
|
Wilba32
|
20 |
2.6K |
0 |
07/04/24 |
07/04/24 |
General
|
20
|
2.6K
|
0
|
|
General
|
|
Re:
Ads that cover whole screen and don’t go away
|
|
Wilba32
|
20 |
2.6K |
1 |
07/04/24 |
07/04/24 |
General
|
20
|
2.6K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
9.4K |
2.7M |
4 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
9.4K
|
2.7M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
9.4K |
2.7M |
1 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
9.4K
|
2.7M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
9.4K |
2.7M |
10 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
9.4K
|
2.7M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
MSB Class Action
|
|
Wilba32
|
218 |
67K |
5 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
218
|
67K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Upcoming Newsflow & Re-rate Estimations
|
|
Wilba32
|
52 |
23K |
24 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
52
|
23K
|
24
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
9.4K |
2.7M |
4 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
9.4K
|
2.7M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Morningstar, Fair value for MSB Shareprice: $2.23/s
|
|
Wilba32
|
11 |
5.0K |
3 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
11
|
5.0K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
9.4K |
2.7M |
10 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
9.4K
|
2.7M
|
10
|
|